Maternal Opioid Use Disorder (MOUD)-CME Paid Option

(1)

Create Account

Availability

On-Demand

Expires on Jun 23, 2029

Cost

$25.00

Credit Offered

1 AMA PRA Category 1 Credit

Overview
Target Audience
Learning Objectives
Speaker
Continuing Medical Education (CME)

This presentation equips Obstetrics (OB) providers and staff with evidence‑based approaches to identify, treat, and support pregnant and postpartum patients with opioid use disorder (OUD), including the use of medication for opioid use disorder (MOUD). It emphasizes the clinical risks of untreated OUD, the importance of integrated care for co‑occurring substance use and mental health conditions, and practical workflows such as SBIRT, care coordination, and Plans of Safe Care. Throughout, it reinforces a trauma‑informed, stigma‑reducing approach that shifts from reporting to responding - helping providers better engage patients, improve outcomes, and support long‑term recovery for mothers and infants.

Hospital and clinic providers, hospital or clinic nursing and care coordination staff, pharmacists, emergency department staff and any interested employee

Explore the impact of OUD and co‑occurring substance use and mental health conditions on maternal and infant outcomes, including the role of overdose in maternal mortality.
Analyze evidence‑based treatment approaches for perinatal OUD, including the use of MOUD/MAT and their benefits for both mother and baby.
Identify key clinical and workflow strategies—such as universal screening (SBIRT), care coordination, and Plans of Safe Care to support patients with OUD and substance use disorder (SUD) in OB settings.
Apply trauma‑informed, stigma‑reducing practices and harm reduction strategies (including naloxone distribution and referral pathways) to improve patient engagement and continuity of care.

Rachael Duncan

Rachael Duncan, PharmD, BCPS, BCCP, is a Colorado-based clinical pharmacist board-certified in pharmacotherapy and critical care pharmacy. She has spent the past decade focused on policy, advocacy, and educational work surrounding opioid stewardship and addiction treatment at both the state and national level. Rachael is the Chief Clinical Officer of Epifluence, where she is Program Director of the Maternal Overdose Matters (MOMs+) Initiative and Associate Director of The Naloxone Project (TNP). She leads several educational and quality improvement initiatives focused on helping hospitals and health systems build addiction treatment infrastructure, with a special focus on rural and frontier communities. She is the author and editor of multiple state- and nation-wide guidelines around opioid stewardship, alternatives to opioids (ALTO) for pain management, and MOUD for addiction treatment, championed ALTO and MOUD across Colorado EDs with the Colorado Hospital Association, and published the first peer-reviewed paper on ALTOs in the ED. Rachael’s clinical experience is in ED and hospital pharmacy.

Continuing Medical Education (CME)

Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Compass Healthcare Collaborative is accredited by the IMS to provide continuing medical education for physicians.

Designation: Compass designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support: This activity was developed without support from any ineligible company. *The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: Compass adheres to the Standards for Integrity and Independence in Accredited Continuing Education. The content of this activity is not related to products or the business lines of an ACCME-defined ineligible company. None of the planners or moderators for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing products used by or on patients.

Note: AMA PRA Category 1 Credits™ are accepted for nursing and other healthcare discipline license renewal purposes, provided the topic is relevant to the applicant’s field or discipline. After participating, you will receive a Certificate of Attendance detailing the number of AMA PRA Category 1 Credits™ you can claim. This certificate is provided for self-reporting requirements and must be submitted to your state board for license renewal.